BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9206749)

  • 1. [Local cyclosporin A therapy of nummuli after epidemic keratoconjunctivitis--case report].
    Reinhard T; Sundmacher R
    Klin Monbl Augenheilkd; 1997 Mar; 210(3):165-8. PubMed ID: 9206749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.
    Levinger E; Slomovic A; Sansanayudh W; Bahar I; Slomovic AR
    Cornea; 2010 Jun; 29(6):638-40. PubMed ID: 20458220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up.
    Sahin A; Bozkurt B; Irkec M
    Cornea; 2008 Feb; 27(2):193-5. PubMed ID: 18216575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Local cyclosporin A in nummuli after keratoconjunctivitis epidemica. A pilot study].
    Reinhard T; Godehardt E; Pfahl HG; Sundmacher R
    Ophthalmologe; 2000 Nov; 97(11):764-8. PubMed ID: 11130165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis.
    Doan S; Gabison E; Gatinel D; Duong MH; Abitbol O; Hoang-Xuan T
    Am J Ophthalmol; 2006 Jan; 141(1):62-66. PubMed ID: 16386977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.
    Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S
    Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrent and persistent nummuli after epidemic keratoconjunctivitis].
    Sundmacher R; Engelskirchen U
    Klin Monbl Augenheilkd; 1991 Jun; 198(6):550-4. PubMed ID: 1895726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of treatment of mooren ulcer with topical cyclosporine a 2%.
    Tandon R; Chawla B; Verma K; Sharma N; Titiyal JS
    Cornea; 2008 Sep; 27(8):859-61. PubMed ID: 18724142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis.
    Okumus S; Coskun E; Tatar MG; Kaydu E; Yayuspayi R; Comez A; Erbagci I; Gurler B
    BMC Ophthalmol; 2012 Aug; 12():42. PubMed ID: 22900547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis.
    Jeng BH; Holsclaw DS
    Cornea; 2011 Sep; 30(9):958-61. PubMed ID: 21673568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful topical cyclosporin A in the therapy of progressive vascularising keratitis in keratitis-ichthyosis-deafness (KID) syndrome (Senter syndrome)].
    Derse M; Wannke E; Payer H; Rohrbach JM; Zierhut M
    Klin Monbl Augenheilkd; 2002 May; 219(5):383-6. PubMed ID: 12094324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phototherapeutic keratectomy (PTK) after epidemic keratoconjunctivitis].
    Quentin CD; Tondrow M; Vogel M
    Ophthalmologe; 1999 Feb; 96(2):92-6. PubMed ID: 10095355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model.
    Moore CP; McHugh JB; Thorne JG; Phillips TE
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):653-9. PubMed ID: 11222523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis.
    Ghanem RC; Vargas JF; Ghanem VC
    Cornea; 2014 Nov; 33(11):1210-3. PubMed ID: 25188789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial.
    De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P
    Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Local cyclosporin A therapy in Thygeson superficial punctate keratitis--a pilot study].
    Reinhard T; Sundmacher R
    Klin Monbl Augenheilkd; 1996 Oct; 209(4):224-7. PubMed ID: 9044962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis.
    Tzu JH; Utine CA; Stern ME; Akpek EK
    Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
    Marsh P; Pflugfelder SC
    Ophthalmology; 1999 Apr; 106(4):811-6. PubMed ID: 10201607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical cyclosporine A 0.5% as a possible new treatment for superior limbic keratoconjunctivitis.
    Perry HD; Doshi-Carnevale S; Donnenfeld ED; Kornstein HS
    Ophthalmology; 2003 Aug; 110(8):1578-81. PubMed ID: 12917176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis.
    Asena L; Şıngar Özdemir E; Burcu A; Ercan E; Çolak M; Altınörs DD
    Eye (Lond); 2017 May; 31(5):781-787. PubMed ID: 28157224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.